Porton Pharma Solutions Ltd. (SHE:300363)

China flag China · Delayed Price · Currency is CNY
23.79
+0.42 (1.80%)
Feb 3, 2026, 3:04 PM CST
50.95%
Market Cap12.62B +51.1%
Revenue (ttm)3.43B +24.5%
Net Income-1.41M
EPS-0.00
Shares Out540.16M
PE Ration/a
Forward PE101.61
Dividendn/a
Ex-Dividend Daten/a
Volume8,729,382
Average Volume16,002,056
Open24.89
Previous Close23.37
Day's Range23.32 - 24.89
52-Week Range12.31 - 30.40
Beta0.71
RSI36.85
Earnings DateApr 4, 2026

About Porton Pharma Solutions

Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial. It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain. It also offers crystallization, bio catalysis, metal catalysis, flow chemistry, prep-chromatography, and milling. The company o... [Read more]

Sector Healthcare
Founded 2005
Employees 4,200
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300363
Full Company Profile

Financial Performance

Financial Statements